Status:
COMPLETED
Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of this clinical study is to determine the safety and efficacy of an investigational drug in patients with Type 2 diabetes mellitus.
Eligibility Criteria
Inclusion
- Patients with Type 2 Diabetes Mellitus with inadequate glycemic control
Exclusion
- Patients with Type 1 Diabetes Mellitus
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
441 Patients enrolled
Trial Details
Trial ID
NCT00106704
Start Date
March 1 2005
End Date
January 1 2007
Last Update
July 1 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.